Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation. Issue 2 (13th December 2018) - Klener, Pavel; Salek, David; Pytlik, Robert; Mocikova, Heidi; Forsterova, Kristina; Blahovcova, Petra; Campr, Vit; Prochazka, Vit; Obr, Ales; Jaksa, Radek; Kuntscherova, Jana; Boudová, Ludmila; et al.